TY - JOUR
TI - Regression of sight-threatening macular edema in type 2 diabetes
following treatment with the anti-tumor necrosis factor monoclonal
antibody infliximab
AU - Sfikakis, PP
AU - Markomichelakis, N
AU - Theodossiadis, GP and
AU - Grigoropoulos, V
AU - Katsilambros, N
AU - Theodossiadis, PG
JO - DIABETES CARE
PY - 2005
VL - 28
TODO - 2
SP - 445-447
PB - AMER DIABETES ASSOC
SN - 0149-5992
TODO - 10.2337/diacare.28.2.445
TODO - null
TODO - null
ER -